Star Imaging and Path Lab Ltd
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]
- Market Cap ₹ 141 Cr.
- Current Price ₹ 81.0
- High / Low ₹ 152 / 46.0
- Stock P/E 7.30
- Book Value ₹ 66.6
- Dividend Yield 0.00 %
- ROCE 26.1 %
- ROE 23.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.1%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 206 days.
- Working capital days have increased from 96.4 days to 142 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 69 | 58 | 78 | 82 | 89 | |
| 54 | 52 | 56 | 53 | 55 | |
| Operating Profit | 15 | 6 | 23 | 29 | 33 |
| OPM % | 21% | 10% | 29% | 35% | 38% |
| 0 | 0 | 1 | 0 | 1 | |
| Interest | 2 | 2 | 2 | 3 | 2 |
| Depreciation | 4 | 3 | 5 | 5 | 6 |
| Profit before tax | 9 | 1 | 16 | 21 | 26 |
| Tax % | 33% | 34% | 23% | 25% | 27% |
| 6 | 1 | 12 | 16 | 19 | |
| EPS in Rs | 42.00 | 3.80 | 82.27 | 11.79 | 11.09 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 224% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | 32% |
| Last Year: | 24% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 14 | 17 |
| Reserves | 17 | 17 | 30 | 34 | 99 |
| 30 | 27 | 31 | 33 | 21 | |
| 10 | 16 | 19 | 18 | 17 | |
| Total Liabilities | 58 | 61 | 81 | 98 | 153 |
| 15 | 19 | 22 | 21 | 25 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 43 | 42 | 60 | 77 | 128 | |
| Total Assets | 58 | 61 | 81 | 98 | 153 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 14 | 6 | 18 | -6 | 23 | |
| -4 | -9 | -7 | -4 | -13 | |
| -7 | -5 | 2 | -0 | 36 | |
| Net Cash Flow | 3 | -7 | 13 | -10 | 46 |
| Free Cash Flow | 10 | -2 | 11 | -10 | 13 |
| CFO/OP | 115% | 115% | 98% | -2% | 91% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 86 | 110 | 151 | 227 | 206 |
| Inventory Days | 24 | ||||
| Days Payable | 398 | ||||
| Cash Conversion Cycle | 86 | 110 | 151 | 227 | -168 |
| Working Capital Days | 6 | -12 | 23 | 124 | 142 |
| ROCE % | 6% | 33% | 34% | 26% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| B2C Revenue Share % |
|
||||
| Number of Diagnostic Centers centers |
|||||
| Total Tests Conducted tests |
|||||
| CT Scans Performed tests |
|||||
| MRI Scans Performed tests |
|||||
| Pathology Tests Performed tests |
|||||
| Team Size employees |
|||||
| B2B Hospital Tie-ups tie-ups |
|||||
Extracted by Screener AI
Documents
Announcements
- Reg. 34 (1) Annual Report.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015-Newspaper Publication in respect of Notice of Annual General Meeting
-
Web-Link To Access The Annual Report-2025-26
- 22nd AGM scheduled for 29 Sep 2026; annual report FY26 shared, remote e-voting 26-28 Sep.
- Notice Of 22Nd Annual General Meeting (AGM) Of The Company For The Financial Year 2025-26
- Reg. 34 (1) Annual Report.
Concalls
-
May 2026Transcript PPT
Business Profile[1]
Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.